Dräger Jaundice Meter JM-105

Effective Jaundice Screening

With the Dräger Jaundice Meter JM-105 you can accurately identify at-risk infants as young as 24 weeks gestational age. Effective screening can decrease readmission rates and durations of stay. Having dependable results in seconds rather than hours increases patient safety and expedites decision making. New integrated flagging feature helps you keep track of patients in need of special attention and comply with your jaundice management protocols.

Easy to use, easy on everyone

Dräger Jaundice Meter JM-105

Building on more than 30 years of proven technology, the Dräger Jaundice Meter JM-105 is a non-invasive transcutaneous bilirubinometer that measures the yellowness of subcutaneous tissue in newborn infants as young as 24 weeks gestational age who have not undergone a transfusion or phototherapy. The JM-105 gives you consistent quality, cost effectively delivered over the lifetime of the device. As a result you can optimise the efficiency of your jaundice program, save time and money, and deliver an exceptional standard of care for your newborns.

The Dräger JM-105 expands the concept of ease of use. It also means an easier experience for all involved. Since thereʼs no blood draw, thereʼs less stress on fragile newborns and their parents – which makes things easier on you. Screening with the JM-105 is fast and easy; simply clean the reusable tip with an alcohol wipe and take your measurement. No fumbling with disposable tips. No recalibration with every baby. Finally, the JM-105 makes it easy for you to get the information you need because it eliminates waiting for laboratory results. And because the device connects to your hospital information system, transferring jaundice screening information to the infantʼs electronic medical record is effortless and accurate. Simply put, the Dräger Jaundice Meter JM-105 is gentle for the newborn and efficient for you.

Improved process and cost efficiency

The Dräger Jaundice Meter JM-105 streamlines jaundice screening practices by eliminating time-consuming blood draws, scheduling of laboratory work, and processing costs. It improves effi ciency by delivering reliable measurements with significantly fewer steps, which frees up more time for direct infant care. The data transfer functionality and barcode scanner help you optimise your screening program and reduce the risk of human error. Because the JM-105 has a reusable probe tip, it requires no disposables. With the volume of screenings performed in nurseries today, the cost of such disposable items can ultimately exceed the initial cost of the device itself. As a result, you save time and money while delivering an exceptional standard of care.

Building on more than 30 years of proven technology, the Dräger Jaundice Meter JM-105 is a non-invasive transcutaneous bilirubinometer that measures the yellowness of subcutaneous tissue in newborn infants as young as 24 weeks gestational age who have not undergone a transfusion or phototherapy. The JM-105 gives you consistent quality, cost effectively delivered over the lifetime of the device. As a result you can optimise the efficiency of your jaundice program, save time and money, and deliver an exceptional standard of care for your newborns.